Skip to main content
. 2020 Sep 2;7:123. doi: 10.3389/fnut.2020.00123

Table 4.

Results of the Mendelian Randomization (MR) analysis for Palmitoleic acid (16:1) and cardiovascular events.

Exposures MR Heterogeneity Pleiotropy
Method beta SE p Method Q p Intercept SE p
Coronary heart disease MR Egger 0.6596 0.6251 0.402 MR-Egger 0.336 0.845 −0.022 0.017 0.331
WM −0.1111 0.3084 0.7186
IVW −0.06957 0.2514 0.782 IVW 1.956 0.586
RAPS −0.07158 0.2659 0.7878
Myocardial infarction MR Egger 0.5029 0.7292 0.5617 MR-Egger 0.485 0.786 −0.015 0.02 0.523
WM 0.07973 0.3459 0.8177
IVW −0.01255 0.2845 0.9648 IVW 1.078 0.782
RAPS −0.01271 0.2963 0.9658
Cardioembolic stroke MR Egger −5.925 4.205 0.2942 MR-Egger 1.163 0.559 0.17 0.098 0.230
WM 1.211 1.266 0.3385
IVW 1.042 1.16 0.3687 IVW 4.075 0.256
RAPS 1.191 1.073 0.2667
Ischemic stroke MR Egger −2.481 1.977 0.3362 MR-Egger 1.775 0.415 0.056 0.047 0.354
WM −0.3666 0.6421 0.5681
IVW −0.1862 0.5075 0.7137 IVW 3.265 0.326
RAPS −0.1927 0.5236 0.7129

WM, Weighted median; IVW, Inverse variance weighted; SE, standard error; beta, beta-coefficients; MR, Mendelian randomization; RAPS, Robust Adjusted Profile Score.